Vaccine News and Research

Latest Vaccine News and Research

People with inflammatory immune conditions had increased risk of COVID-19-related death before vaccination

People with inflammatory immune conditions had increased risk of COVID-19-related death before vaccination

Zoonotic origins of seasonal human coronaviruses

Zoonotic origins of seasonal human coronaviruses

Molecule in mosquito saliva can be a potential new target for halting deadly diseases

Molecule in mosquito saliva can be a potential new target for halting deadly diseases

Getting fully vaccinated against COVID-19 during pregnancy helps protect young infants

Getting fully vaccinated against COVID-19 during pregnancy helps protect young infants

Chicken vaccination leads to better growth of Kenyan children in agriculture-dependent families

Chicken vaccination leads to better growth of Kenyan children in agriculture-dependent families

Pregnant people in Sub-Saharan Africa are at higher risk of complications and death from COVID-19

Pregnant people in Sub-Saharan Africa are at higher risk of complications and death from COVID-19

The cumulative risk of myocarditis/myopericarditis among global mRNA-1273 recipients

The cumulative risk of myocarditis/myopericarditis among global mRNA-1273 recipients

Longitudinal kinetics of the serological response in COVID-19 recovered patients over a period of 14 months

Longitudinal kinetics of the serological response in COVID-19 recovered patients over a period of 14 months

Pregnant women's social contacts and COVID vaccination coverage in 19 European countries

Pregnant women's social contacts and COVID vaccination coverage in 19 European countries

Researchers plan to commence a clinical trial on new COVID-19 inactivated vaccine

Researchers plan to commence a clinical trial on new COVID-19 inactivated vaccine

Molnupiravir reduces hospitalizations and deaths in at-risk, unvaccinated adults with COVID

Molnupiravir reduces hospitalizations and deaths in at-risk, unvaccinated adults with COVID

OpenSAFELY study shows the effectiveness of Pfizer COVID booster doses

OpenSAFELY study shows the effectiveness of Pfizer COVID booster doses

People with HIV are at greater risk of breakthrough COVID-19 infections after vaccination

People with HIV are at greater risk of breakthrough COVID-19 infections after vaccination

Com-COV 3 study focuses on assessing a third dose booster vaccination for young people aged 12 to 15

Com-COV 3 study focuses on assessing a third dose booster vaccination for young people aged 12 to 15

COVID-19 vaccination may offer less effective and shorter-lasting protection for some cancer patients

COVID-19 vaccination may offer less effective and shorter-lasting protection for some cancer patients

The effect of Omicron breakthrough infection on the magnitude and breadth of serum neutralizing activity and memory B cells among BNT162b2 vaccinees

The effect of Omicron breakthrough infection on the magnitude and breadth of serum neutralizing activity and memory B cells among BNT162b2 vaccinees

Influenza vaccination rates of health and aged care facility staff during the COVID-19 pandemic

Influenza vaccination rates of health and aged care facility staff during the COVID-19 pandemic

Omicron lineage spike proteins use ACE2 receptors more efficiently

Omicron lineage spike proteins use ACE2 receptors more efficiently

Details of SARS-CoV-2 seroprevalence surveys supported by the US CDC

Details of SARS-CoV-2 seroprevalence surveys supported by the US CDC

Addressing the ‘trust factor’: South Carolina researchers tackle health disparities using genetics

Addressing the ‘trust factor’: South Carolina researchers tackle health disparities using genetics

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.